[pT1G3 bladder carcinoma: our experience]

Arch Ital Urol Androl. 1996 Feb;68(1):9-11.
[Article in Italian]

Abstract

Approximately 6 to 23% of the patients with transitional cell carcinoma confined to the superficial mucosa of the bladder suffer for a pT1G3 tumor. Between 1984 and 1994, 12 patients were treated for high grade stage T1 tumores. Trans-urethral resection of the bladder cancer was performed in 8 patients, supported in two cases by immunotherapy with B.C.G. and in one case by endovesical chemotherapy. Radical cystectomy was carried out in 4 patients. Our results are similar to what reported by other Authors, but we didn't have any progression in all 8 patients treated with conservative therapy.

Publication types

  • English Abstract

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use
  • BCG Vaccine / therapeutic use
  • Carcinoma, Transitional Cell / pathology
  • Carcinoma, Transitional Cell / surgery
  • Carcinoma, Transitional Cell / therapy*
  • Combined Modality Therapy
  • Cystectomy
  • Follow-Up Studies
  • Humans
  • Immunotherapy
  • Mitomycin / therapeutic use
  • Time Factors
  • Urinary Bladder / pathology
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / surgery
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antibiotics, Antineoplastic
  • BCG Vaccine
  • Mitomycin